|
|
||||||||
J Thorac Cardiovasc Surg 2003;126:529-536
© 2003 The American Association for Thoracic Surgery
Surgery for congenital heart disease |
a Division of Pediatric Cardiothoracic Surgery, Childrens Hospital, Columbus, The Ohio State University Medical Center, Columbus, Ohio, USA
b Division of Cardiology, Childrens Hospital, Columbus, The Ohio State University Medical Center, Columbus, Ohio, USA
Received for publication August 1, 2002; revisions received October 1, 2002; revisions received November 11, 2002; accepted for publication December 27, 2002.
* Address for reprints: Samuel Weinstein, MD, Department of Thoracic Surgery, Childrens Hospital, Columbus, Education BuildingRoom 642, 700 Childrens Drive, Columbus, OH 43205, USA
Weinstes{at}chi.osu.edu
| Abstract |
|---|
|
|
|---|
METHODS: Ten patients (mean age 21.1 ± 7.0 years) underwent extracardiac Fontan conversion, cryoablation, and pacemaker placement between November 1999 and April 2002 (13.1 ± 4.1 years after the original atriopulmonary connection). Eight patients were in New York Heart Association class III and 2 were in New York Heart Association class IV. Nine patients had clinically important intra-atrial reentry tachycardia refractory to medical therapy.
RESULTS: Follow-up was between 3.1 and 32.6 months (16.8 ± 9). One death occurred at 7 days after surgery due to sepsis and multisystem organ failure. The second death occurred at 48 days from complications of protein-losing enteropathy. The second patient with protein-losing enteropathy had improved New York Heart Association classification, cessation of albumin transfusions, and a normal stool alpha antitrypsin level (down from 4.1 mg/g preoperatively). Five patients improved to New York Heart Association class I and 3 patients to New York Heart Association class II. Sustained arrhythmias could not be induced in any patient. Seven patients are on no antiarrhythmics. One patient had recurrence of intra-atrial reentrant tachycardia 11 months postoperatively, which required electrical cardioversion; this patients symptoms are currently well controlled on 1 medication.
CONCLUSION: Extracardiac Fontan, cryoablation, and pacemaker placement reduced atrial arrhythmias and improved New York Heart Association classification in all surviving patients. In selected patients, this operation offers improvement in clinical outcome and is an alternative to transplantation. Protein-losing enteropathy may not be a contraindication to performing Fontan conversion with cryoablation.
|
Since the first successful atriopulmonary connection (APC) was reported by Fontan in 1971, the Fontan procedure has been applied to palliate multiple forms of functional single ventricle.1 Long-term sequelae of an atriopulmonary Fontan have been well described and include intra-atrial reentrant tachycardia (IART), pulmonary and systemic venous obstruction, thromboembolism, protein-losing enteropathy (PLE), and decreased cardiac output.2-6
The increased right atrial flow and suture load that these patients experience from the time of the original Fontan have been felt to be one cause of their atrial arrhythmias. The arrhythmias can further increase right atrial pressure, which leads to a negative cycle that leads to considerable morbidity and mortality.2,3,7 Atrial arrhythmias have been reported between 22% and 50% of patients with an APC Fontan.2,3,7 PLE is seen in between 3.7% and 10% of patients but has very high rates of morbidity and mortality.2,5 The mortality rate within 5 years of the diagnosis of PLE is 40%.5 Although not always clinically apparent, atrial thrombus was reported in 33% of patients having undergone a variety of different Fontan-type operations.6
Total cavopulmonary connection (TCPC) has been one of the modifications to the Fontan operation suggested to improve atrial flow characteristics and hopefully avoid right atrial distention, arrhythmia, and the other long-term sequelae seen with APCs.8,9 This adjustment and other modifications, such as fenestration and modified ultrafiltration, have decreased the morbidity and mortality rates from a Fontan operation in the current era, but more time will be needed to evaluate the long-term complications of the TCPC Fontan operation.5,10-13
Conversion of an atriopulmonary Fontan to a lateral tunnel or extracardiac Fontan has been attempted to alleviate complications by improving central systemic flow patterns. Many authors hoped that lowering central venous pressure would reduce atrial distention and decrease the presence of atrial arrhythmias.14-16 In recent reviews of patients undergoing Fontan revision by conversion to an extracardiac tunnel, half of the patients received no relief from their arrhythmia or had a new arrhythmia develop after the revision surgery.14-16 Kreutzer and colleagues,16 reviewing the Boston experience, reported on 8 patients undergoing conversion of a modified Fontan to a lateral atrial tunnel Fontan. Two of the 8 patients had PLE, defined in this study as a serum albumin concentration less then 2 g/dL with a requirement for albumin replacement at least once every 3 months. Four of 6 patients with an arrhythmia preoperatively still had intra-atrial reentrant tachycardia postoperatively. Additionally, neither of the 2 patients in this study with PLE undergoing Fontan revision had improvement of this condition.16
Mavroudis and associates have demonstrated that revision of an APC Fontan, with the addition of cryoablation of the foci of the IART, has markedly improved the outcome for these patients.17-20 With a combination of preoperative and intraoperative mapping, Deal and colleagues20 have identified the anatomic circuits responsible for the atrial arrhythmias in this cohort of patients. In their most recent report of 40 patients undergoing total cavopulmonary conversion, atrial cryoablation, and permanent pacemaker placement for failed atriopulmonary Fontans, arrhythmia recurrence was only 12.5%.17 Right atrial cryoablation was performed in all patients for atrial flutter. Those patients with atrial fibrillation also received left atrial cryoablation, or a Cox maze III procedure. Only 10% of the patients received long-term antiarrhythmic medications postoperatively, and 85% of the patients were in New York Heart Association (NYHA) class I or II after the procedure.17
Like other institutions, we have struggled with the approach to treating patients with APC Fontans who are symptomatic with IART. We applied Mavroudis and Deals approach in our population and we review our experience, which includes 8 patients with intractable IART, 2 with systemic venous obstruction, 2 patients with PLE, and all with poor NYHA classification.
| Patients and materials |
|---|
|
|
|---|
|
One patient had a history of thromboembolic events and while awaiting the procedure on the elective schedule was admitted urgently for surgery secondary to a pulmonary embolus. Two patients had a hemodynamically significant systemic venous obstruction, and 1 patient was cyanotic. All patients underwent catheterization before the operation, and their hemodynamic and oxygen saturation data are represented in Table 2.
|
Operative and cryoablation procedure
The surgical technique applied was similar to that described by Mavroudis and colleagues17-19 from Childrens Memorial Hospital in Chicago.
All patients were converted to an extracardiac Fontan (ECF). The conduct for the creation of the TCPC was dictated by the previous atriopulmonary or cavopulmonary connection. Three patients with a bidirectional Glenn shunt had the addition of an extracardiac polytetrafluoroethylene (PTFE) tube graft to the right pulmonary artery, while patients with only an APC underwent both a bidirectional Glenn shunt and an ECF. One patient with a classic Glenn shunt had continuity restored between the right and left pulmonary arteries with homograft tissue before the placement of an extracardiac tube graft from the inferior vena cava (IVC) to the right pulmonary artery. Another patient had both a left and right superior vena cava and both a left and right IVC. This patient underwent bilateral bidirectional Glenn shunts and had an ECF created via a PTFE tube graft to the right pulmonary artery from a constructed confluence of the right and left IVC of autologous atrial tissue.
All ECFs were performed with PTFE grafts of size 20 to 24, and none were fenestrated. Resternotomy with standard technique was performed in all patients. Femoral vessels were dissected electively in 3 patients before resternotomy, and 2 of these patients were placed on groin bypass urgently due to falling saturations and blood pressure during sternal dissection. Once normothermic bypass was instituted the heart was kept beating until all of the relevant vessels for reconstruction were visualized.
Patients underwent transesophageal echocardiography preoperatively, and an intraoperative bubble study was performed to confirm the absence or presence of an atrial septal defect. All patients had right atrial cryoablation performed, although only the 2 patients with atrial fibrillation documented preoperatively received left atrial cryoablation. In an attempt to minimize cardiac ischemic time, patients whose atrial septum was intact underwent cryoablation within the right atrium with the heart beating. After placement of cryoablative lesions, patients were cooled to 28°C and the heart was arrested. An atrial septectomy was then performed, and a considerable amount of atrial tissue was excised before atriotomy closure to markedly reduce atrial cavity size. Previous right atrial suture lines, as in a Björk modification, were excised when not included within the cryoablation lines. After atrial closure, all hearts were reperfused and the specific type of Fontan revision for that patient was carried out with the heart beating and patient rewarming.
The right atrial cryoablation lesions were placed in 4 distinct locations as described by Mavroudis and colleagues19: (1) between the posterior rim of the atrial septal defect to the posterior edge or resected atrial wall; (2) between the superior aspect of the ASD and the area of resected right atrial appendage; (3) from the IVC to the rim of the coronary sinus os; and (4) from the IVC to the annulus of the right-sided atrioventricular valve (Figure 1).
|
|
|
| Results |
|---|
|
|
|---|
Mean follow-up was between 3.1 and 32.6 months (16.8 ± 9.5 months). There were 8 survivors and 2 deaths. All survivors had improved NYHA classification. Of the 8 survivors, 5 patients are currently classified NYHA class I and 3 are NYHA class II (Figure 4).
|
One patient died 7 days postoperatively of sepsis and multisystem organ failure. This patient had a history of mediastinitis with secondary healing of her sternum from her original APC. Her conversion surgery was notable for a lengthy dissection of her mediastinal adhesions, reconstruction of bilateral superior vena cava, bilateral IVC, and she required reexploration for postoperative hemorrhage. On postoperative day 4 she cultured positive for Staphylococcus aureus, as she did after her initial APC. The other patient who died was 1 of the 2 patients in this series with PLE. This patient showed significant improvement in his cardiac output and IART control but continued to have drainage of serous fluid from his mediastinal wound and femoral vessel dissection site. He received multiple transfusions of albumin and gamma globulin without clinical improvement. Despite severe malnutrition he refused enteral or parenteral nutrition. At postoperative day 42 he was readmitted to the hospital with malnutrition and sepsis. On day 48 after surgery, he died of sepsis and multisystem organ failure.
The other patient in our series with PLE has shown remarkable improvement. Now 14 years old, she no longer requires albumin transfusion therapy. Her last stool alpha antitrypsin level was 2.6 mg/g, down from 4.1 mg/g preoperatively (normal
2.6 mg/g). Her exercise tolerance has improved substantially. Wheelchair-bound preoperatively, she now participates in school gym class. She is currently undergoing a slow taper of steroids, which she continues to use for arthritic symptoms.
IART was not present in any patient at the time of discharge. Patients with permanent pacemakers underwent electrophysiologic testing via their pacing system within 2 months of surgery to determine the inducibility of IART. Standard pacing protocols using extrastimuli of singles, doubles, and triples were applied. Four patients were not inducible. Two patients had nonsustained atrial tachycardia induced, defined as less than 1 minute. No patient has had a significant atrial arrhythmia by clinical history.
One patient with giant atria, pulmonary embolism, and atrial fibrillation/flutter has had no episodes of tachyarrhythmia postoperatively for 1 year but recently had antiarrhythmic therapy restarted with sotalol for paroxysmal episodes of IART. This patient has had no further thromboembolic events since surgery (>24 months). His chest x-ray films preoperatively and postoperatively represent the potential nidus for thrombus formation and the substantial change seen in atrial cavity size after atriectomy (Figure 5).
|
| Discussion |
|---|
|
|
|---|
There is considerable data suggesting that interruption of IART with cryoablation in a failed Fontan, in addition to right atrial reduction and conversion to an extracardiac connection, will result in superior hemodynamics and an improvement in IART management.14-20,25,26
In comparison, conversion of an atriopulmonary Fontan to a total cavopulmonary Fontan without arrhythmia circuit cryoablation has been shown to result in a very high level of recurrence.14-18 Deal and colleagues,20 in 1998, reported a comparison of patients from the same center undergoing Fontan revision with and without concomitant cryoablation. All patients who underwent revision alone experienced recurrent symptomatic atrial tachycardia, while the group having cryoablation had only a 10% recurrence rate.20 Mavroudis group19 and Deals group20 have impressively mapped the areas where there is substrate for the production of reentrant circuits in the right atrium. Their work has followed the extensive work by Gandhi and colleagues,25,26 who in a canine model showed that surgical incisions from the Fontan are the nidus for the arrhythmia and that interruption of these areas are necessary to effectively treat the IART.
We believe that our experience compares favorably with previous reports of Fontan conversion and cryoablation. In our series, surviving patients clearly have improved hemodynamics, and all but 1 patient has been relieved of the burden of antiarrhythmic medication. This patient is well controlled on 1 medication. We have had 2 mortalities in this group of 10 patients. The Chicago group has seen 1 death and 3 patients go on to transplantation, suggesting a treatment failure of 10% in their last reported series of 40 patients.17 Our higher failure rate may be due to the older age of our patients at presentation for surgery, the small number of patients in our series, or the inclusion of patients with PLE.
We believe that this is the first report of Fontan conversion and cryoablation being performed in patients with PLE. One of our 2 patients with PLE did show a complete resolution of her dependency on chronic infusion therapy. She was in NYHA class IV before operation and improved to NYHA class I after the procedure. Her heparin, albumin, and intravenous immunoglobulin transfusions have been discontinued and her last stool alpha antitrypsin level was normal.
Although we cannot recommend Fontan conversion with cryoablation as specific therapy for PLE, we do not feel that the presence of PLE is a contraindication to the procedure if arrhythmia or hemodynamic data suggest that the surgery is indicated. Both patients with PLE had gradients from right atrium to pulmonary artery of 2 and 3 mm Hg, which were relieved with an extracardiac tube. The surviving patient had more severe atrial arrhythmias, but both patients IART was well controlled after cryoablation. The surviving patient was younger, with reasonable medical control of her PLE, and the patient who succumbed was over 30 years old, with severe ascites and poor compliance with medical therapy for over a decade. These factors may present a variable that relates to why 1 patients PLE resolved while the other patient died of complications from the same disease.
The patient with a history of cerebral vascular accidents and recurrent pulmonary emboli has seen significant relief from both his recurrent pulmonary emboli and intra-atrial reentrant tachycardia. He has not had a thromboembolic event more than 2 years since surgery and his atrial fibrillation and flutter are well controlled.
We elected to perform right atrial cryoablation on every patient, including 2 patients who did not have IART preoperatively. Our group feels this is the proper approach based on Deal and colleagues work20 in identifying the anatomic circuits responsible for IART in patients with APC Fontans. Previous right atrial suture lines are resected during the procedure and it adds little technically to perform cryoablation within the right atrium. Currently, we choose not to add left atrial cryoablation in the absence of atrial fibrillation. This requires opening the left atrium and increasing cardiac ischemic time.
None of the patients in this series received a fenestrated Fontan. As well, patients in whom the pulmonary artery was still connected to the heart resulting in some percentage of pulsatile flow did not receive a pulmonary artery disconnection. We believe that adult patients with a preexisting Fontan represent a different cohort physiologically than the typical 2- or 3-year-old child coming for a Fontan operation today. These adult patients have already made their transition to passive pulmonary blood flow and have proven that Fontan physiology will be tolerated. We have not seen these adolescent and adult patients experience pulmonary vascular reactivity affecting their cardiac output. In addition, we have found that fenestrations in extracardiac Fontans do not stay open as long or as reliably as in a lateral tunnel Fontan.
DDD pacemakers were placed in 9 patients. Although the Chicago group places atrial antitachycardia pacemakers only, we were worried in our early experience that our patients might experience atrioventricular node dysfunction. Transvenous access for a ventricular lead after this surgery would be difficult, and placement would require a thoracotomy. Currently, 2 patients are in sinus rhythm, 2 are ventricular sensing and atrial pacing, and 4 patients are pacing both atria and ventricles.
We believe that this procedure is effective in improving a patients symptoms of heart failure and in reducing the recurrence of IART. Based on the improvement in NYHA failure classification for all surviving patients, we believe there is clinical evidence that cardiac output is improved.
Transplantation can offer a viable option in this patient population. However, the success of pediatric cardiac transplantation is equivalent to the reported results of Fontan revision and cryoablation,17,27,28 as well as our center. In addition, the morbidity rates of transplantation in Fontan patients have been noted to be higher than for other subgroups undergoing cardiac replacement therapy.27 The morbidity and mortality rates associated with immunosuppression, in addition to the limited availability of organs for transplantation, would suggest that surgical conversion with cryoablation is preferable in this subset of patients. This approach results in clinically important palliation of patient symptoms and does not preclude cardiac transplantation as a future option. We currently offer Fontan conversion with cryoablation for this cohort of patients before considering transplantation.
| Conclusion |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
D. L.S. Morales, D. J. Dibardino, B. E. Braud, A. L. Fenrich, J. S. Heinle, W. K. Vaughn, E. D. McKenzie, and C. D. Fraser Jr Salvaging the Failing Fontan: Lateral Tunnel Versus Extracardiac Conduit Ann. Thorac. Surg., October 1, 2005; 80(4): 1445 - 1452. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-H. Kim, H. G. Lim, J. R. Lee, J. R. Rho, E. J. Bae, C. I. Noh, Y. S. Yoon, and Y. J. Kim Fontan conversion with arrhythmia surgery Eur J Cardiothorac Surg, February 1, 2005; 27(2): 250 - 257. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |